Home/Filings/4/0000950170-25-094387
4//SEC Filing

Postma Robert W 4

Accession 0000950170-25-094387

CIK 0001107421other

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 7:11 PM ET

Size

8.8 KB

Accession

0000950170-25-094387

Insider Transaction Report

Form 4
Period: 2025-07-03
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-07-03+6,4006,400 total
    Exercise: $5.00Exp: 2035-07-03Common Stock (6,400 underlying)
  • Award

    Common Stock

    2025-07-03+4,05033,133 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    24
  • Common Stock

    (indirect: By WaterMill Asset Management Corp.)
    62,416
Footnotes (3)
  • [F1]Represents a grant of restricted stock units (RSUs) which immediately vested upon grant. After the reported acquisition of the RSUs, the reporting person owned in aggregate 33,133 shares of common stock (29,083 previously owned shares, plus the instant grant of 4,034 RSUs).
  • [F2]The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.
  • [F3]One-twelfth of the Option vests each month on the monthly anniversary of July 3, 2025, with any amount that remains unvested on the date immediately preceding the Company's 2026 annual general meeting of stockholders vesting thereon.

Documents

1 file

Issuer

Alaunos Therapeutics, Inc.

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001827847

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 7:11 PM ET
Size
8.8 KB